◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
盟科药业 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
+Revenue 130.0M 90.8M 48.2M 7.7M 0.00 0.00 1.1M
Revenue Growth % 43.2% 88.3% 529.3% -- -- -100.0% --
Total Revenue 130.0M 90.8M 48.2M 7.7M 0.00 0.00 1.1M
Cost Of Revenue 22.4M 16.7M 8.8M 578,400 -- -- 203,100
+Gross Profit 107.6M 74.1M 39.4M 7.1M -- -- 890,300
Gross Margin % 82.8% 81.6% 81.7% 92.4% -- -- 81.4%
Total Operating Cost 583.0M 539.0M 315.0M 280.0M 96.9M 127.0M 167.0M
Selling Expenses 110.0M 107.0M 82.5M 66.2M 4.4M -- --
Admin Expenses 66.3M 61.2M 63.7M 58.2M 36.5M 31.4M 24.8M
Rd Expenses 369.0M 345.0M 150.0M 152.0M 54.3M 95.4M 142.0M
Finance Expenses 13.4M 8.1M 10.1M 3.2M 1.5M -34,700 -229,500
+Operating Income -434.0M -411.0M -223.0M -256.0M -96.8M -125.0M -150.0M
Operating Margin % -333.8% -452.8% -462.6% -3342.0% -- -- -13718.7%
Non Operating Income -- -- 3.7M 29.9M 10.5M 9.3M --
Non Operating Expenses 22,900 4.2M 1.1M 21,600 9,900 14,600 37,100
Fair Value Change Income 17.1M 33.3M 18.5M 10.5M -140,500 -398,200 1.1M
Asset Disposal Income 27,500 1,500 513,700 -- -3,900 -- 32,000
Asset Impairment Loss -- -- -- 181,200 -- -- 289,400
Other Income 1.4M 3.8M 25.3M 6.1M 251,900 2.4M 14.9M
Income Before Tax -435.0M -415.0M -220.0M -226.0M -86.3M -115.0M -150.0M
Income Tax 6.2M 6.0M 5,381 38,900 5,518 -- 5,293
+Net Income -441.0M -421.0M -220.0M -226.0M -86.3M -115.0M -150.0M
Net Margin % -339.2% -463.8% -456.4% -2950.4% -- -- -13718.7%
Net Income Attributable -441.0M -421.0M -220.0M -226.0M -86.3M -115.0M -150.0M
Eps Basic -0.67 -0.64 -0.38 -0.43 -0.34 -- --
Eps Diluted -0.67 -0.64 -0.38 -0.43 -0.34 -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
Cash And Equivalents 386.0M 166.0M 151.0M 146.0M 227.0M 22.4M 20.5M
Trading Financial Assets 207.0M 787.0M 1.1B 326.0M 410.0M 30.2M --
Accounts Receivable 31.9M 22.0M 11.1M 1.4M -- -- --
Notes And Accounts Receivable 31.9M 22.0M 11.1M 1.4M -- -- --
Prepayments 18.7M 32.1M 49.2M 13.8M 12.5M 5.4M 8.0M
Inventory 52.9M 37.5M 21.9M 11.0M 5.6M -- --
Total Current Assets 749.0M 1.1B 1.4B 510.0M 662.0M 63.1M 37.9M
Fixed Assets -- 7.5M 7.1M 2.5M 666,900 994,700 1.5M
Fixed Assets Total 5.8M 7.5M 7.1M 2.5M 666,900 994,700 1.5M
Construction In Progress -- -- -- 15.7M 350,200 -- --
Construction In Progress Total -- -- -- 15.7M 350,200 -- --
Intangible Assets 1.7M 1.9M 2.2M 838,200 132,900 125,000 156,900
Long Term Deferred Expenses 19.1M 21.7M 22.7M 1.8M 2.6M 3.9M 5.1M
Total Non Current Assets 100.0M 114.0M 127.0M 139.0M 6.9M 5.7M 7.4M
Total Assets 849.0M 1.2B 1.5B 649.0M 669.0M 68.8M 45.3M
Short Term Borrowings 5.0M -- 48.8M 50.1M -- -- --
Accounts Payable 74.8M 79.6M 25.7M 10.8M 10.1M 27.4M 52.2M
Contract Liabilities -- 133,100 -- -- -- -- --
Total Current Liabilities 212.0M 137.0M 115.0M 94.2M 33.2M 37.3M 56.1M
Long Term Borrowings 123.0M 115.0M 70.0M -- -- -- --
Total Non Current Liabilities 198.0M 198.0M 168.0M 116.0M 15.5M 82.2M 4.2M
Total Liabilities 410.0M 335.0M 283.0M 210.0M 48.7M 119.0M 60.3M
Paid In Capital 656.0M 655.0M 655.0M 525.0M 525.0M 226.0M 226.0M
Capital Reserve 1.6B 1.5B 1.5B 637.0M 591.0M 511.0M 432.0M
Retained Earnings -1.8B -1.4B -943.0M -723.0M -496.0M -788.0M -672.0M
Equity Attributable 439.0M 834.0M 1.2B 438.0M 620.0M -50.7M -14.9M
Total Equity 439.0M 834.0M 1.2B 438.0M 620.0M -50.7M -14.9M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
Cash From Sales 137.0M 91.4M 45.1M 8.0M -- -- 1.1M
Tax Refunds Received -- 12.8M 7.3M -- -- -- --
Total Operating Cash Inflow 140.0M 108.0M 72.9M 46.3M 18.3M 18.7M 1.7M
Cash Paid For Goods 416.0M 316.0M 216.0M 147.0M 73.8M 103.0M 121.0M
Cash Paid To Employees 111.0M 105.0M 88.6M 70.9M 30.4M 26.4M 24.4M
Taxes Paid 27.0M 3.0M 141,700 385,000 468,100 3,414 31,200
Total Operating Cash Outflow 587.0M 437.0M 313.0M 227.0M 108.0M 131.0M 151.0M
Operating Cash Flow -447.0M -329.0M -240.0M -181.0M -89.3M -112.0M -149.0M
Total Investing Cash Inflow 3.0B 3.9B 1.5B 1.8B 700.0M -- 150.0M
Total Investing Cash Outflow 2.5B 3.6B 2.2B 1.8B 1.1B 30.1M 92.9M
Investing Cash Flow 515.0M 335.0M -733.0M 22.2M -379.0M -30.1M 57.2M
Cash From Borrowings 105.0M 60.0M 149.0M 53.2M 6.6M 100.0M --
Dividends And Interest Paid 6.5M 4.6M 3.3M 697,100 2.4M -- 56,600
Debt Repayments 17.0M 59.8M 70.0M 9.7M -- 30.0M 3.5M
Total Financing Cash Inflow 107.0M 60.0M 1.1B 58.3M 683.0M 174.0M 102.0M
Total Financing Cash Outflow 38.9M 79.6M 102.0M 30.7M 11.0M 30.0M 3.6M
Financing Cash Flow 68.1M -19.6M 1.0B 27.7M 672.0M 144.0M 98.1M
Net Change In Cash 136.0M -13.6M 55.9M -131.0M 204.0M 1.9M 6.5M
Ending Cash Balance 273.0M 137.0M 151.0M 95.2M 227.0M 22.4M 20.5M
Capex 914,800 7.7M 12.2M 22.9M 799,500 113,800 5.9M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...